التداخل بين بيكلوميثازون وفلوسينونيد

Lung function (FEV 1 or PEF), beta‑agonist use, and asthma symptoms should be carefully monitored during withdrawal of oral or other systemic corticosteroids.

Patients requiring oral or other systemic corticosteroids should be weaned slowly from oral or other systemic corticosteroid use after transferring to QVAR REDIHALER.

Use of more than one corticosteroid-containing product at the same time may increase the total systemic absorption of topical corticosteroids.